mav,
my initial thoughts. When thinking about a retail CR from the companies POV:
1) too much time and effort which detracts from producing the drugs. Simply not enough manpower = cost
2) cost of raising money in retail (lawyers, brokers etc) is rediculous.
3) risk of falling flat at the end of the day.
The real weights now rest on if they can get some things done and proved by the time the need more cap in 12 - 16 months. Be it through results or licencing. The market should allow us to have a go close to 3c too though, they usually make sure of that.
Sol
- Forums
- ASX - By Stock
- PAB
- the slide continues
the slide continues, page-29
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $10.97K | 3.626M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 31554019 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 27089307 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
41 | 31554019 | 0.003 |
24 | 27131332 | 0.002 |
15 | 54551999 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 27089307 | 15 |
0.005 | 11226512 | 10 |
0.006 | 3371450 | 5 |
0.007 | 6601356 | 5 |
0.008 | 1221910 | 4 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |